Rusan’s API plant in Ankleshwar receives USFDA GMP approval
Rusan Pharma plans to expand its portfolio with additional APIs, including Apomorphine, Buprenorphine, Naloxone, Naltrexone,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ankleshwar
Lupin’s Ankleshwar facility wins Par Excellence Award at 33rd National Convention on Quality Concept
The company's nomination summarised its transformation project to improve the yield and quality of Cefadroxil products
Zydus Cadila gets EIR from US FDA for Ankleshwar facility
The EIR report stated that the classification of the facility is "No Action Indicated (NAI)", the company added
Sanofi India to sell Ankleshwar site to Zentiva
Board of Directors approve slump sale and transfer of the manufacturing facility
The Board of Directors of Sanofi India has…
Cadila Pharma celebrates World Day for Safety and Health at Work
Activities conducted at Bhat, Dholka, Ankleshwar, Kadi and Hirapur locations to commemorate International Labour Organisation